Skip to main content
Clinical Trials/ISRCTN76503336
ISRCTN76503336
Active, Not Recruiting
N/A

Detection, linkage to care, treatment, and monitoring of hypertension: a quasi-experimental study in coastal communities in Accra - The Ghana Heart Initiative Hypertension study protocol

Deutsche Gesellschaft für Internationale Zusammenarbeit0 sites10,000 target enrollmentOctober 4, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Detection, and treatment of hypertension and prevention of hypertension-associated target organ damage
Sponsor
Deutsche Gesellschaft für Internationale Zusammenarbeit
Enrollment
10000
Status
Active, Not Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 4, 2023
End Date
October 4, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Deutsche Gesellschaft für Internationale Zusammenarbeit

Eligibility Criteria

Inclusion Criteria

  • Current inclusion criteria as of 20/05/2024:
  • 1\. Resident in the Greater Accra Region of Ghana
  • 2\. Resident in the selected urban coastal communities
  • 3\. Aged 18 years or older as of last birthday
  • 4\. Have no intention of relocating outside of the study communities prior to enrolment and during the study period
  • 5\. Have a three\-time blood pressure recording with a mean of \=140/90mmhg at the time of recruitment
  • 6\. Newly diagnosed hypertensive; and
  • 7\. Willing to participate and has the ability to give consent.
  • Previous inclusion criteria:
  • Adults 18 years and above in coastal communities in the Greater Accra Region of Ghana

Exclusion Criteria

  • 1\. Not a resident of the Greater Accra region and the selected coastal communities
  • 2\. Residents who intend to travel or re\-locate before or during the study period
  • 3\. Known hypertensive participants who are already on medication
  • 4\. Known end\-organ dysfunction on treatment
  • 5\. Not willing to participate in the study or do not give consent

Outcomes

Primary Outcomes

Not specified

Similar Trials